Main concepts on bioequivalence and biosimilarity in the Chilean legislation, and current controversies on drug interchangeability

Medicines are an economic good and a fundamental component of public and private spending and health decision-making. Assurance of their quality, efficiency and safety is essential. However, the variety of products on the Chilean market, including innovative and generic products—the latter accounted...

Full description

Bibliographic Details
Main Authors: Jana Stojanova, Mariane Lutz, Gabriel Lazcano, Marcelo Arancibia
Format: Article
Language:English
Published: Medwave Estudios Limitada 2020-01-01
Series:Medwave
Subjects:
Online Access:https://www.medwave.cl/link.cgi/Medwave/Enfoques/ProbSP/7825.act